These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9199041)

  • 21. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
    Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
    Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer].
    Ishikawa A
    Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of DNA ploidy combined with a cytometric proliferation index of imprints from core needle biopsies in prostate cancer.
    Ahlgren G; Falkmer U; Gadaleanu V; Abrahamsson PA
    Eur Urol; 1999 Oct; 36(4):314-9. PubMed ID: 10473991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric DNA analysis of stage D2 prostatic carcinoma.
    Yokogi H; Mizutani M; Ishibe T
    Urol Int; 1991; 47(2):57-9. PubMed ID: 1792707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications.
    Tinari N; Natoli C; Angelucci D; Tenaglia R; Fiorentino B; Di Stefano P; Amatetti C; Zezza A; Nicolai M; Iacobelli S
    Cancer; 1993 Feb; 71(4):1289-96. PubMed ID: 8435806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects.
    Forsslund G; Nilsson B; Zetterberg A
    Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
    Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
    Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phosphatase and prostate specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma.
    Stege R; Lundh B; Tribukait B; Pousette A; Carlström K; Hasenson M
    J Urol; 1990 Aug; 144(2 Pt 1):299-302. PubMed ID: 1695689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
    Abaza R; Diaz LK; Laskin WB; Pins MR
    J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.
    Frankfurt OS; Chin JL; Englander LS; Greco WR; Pontes JE; Rustum YM
    Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumor heterogeneity of DNA ploidy and correlations with clinical stage and histologic grade in prostate cancer.
    Kucuk O; Demirer T; Gilman-Sachs A; Taw I; Mangold M; Singh S; Westerman MP
    J Surg Oncol; 1993 Nov; 54(3):171-4. PubMed ID: 8412173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA ploidy: early malignant lesions.
    Lieber MM
    J Cell Biochem Suppl; 1992; 16H():44-6. PubMed ID: 1289672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Flow cytometric analysis of prostatic adenocarcinomas after hormone therapy].
    Hayashi T; Mouri J; Kurosu S; Chiba R; Yokota T; Yamaguchi S
    Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):339-45. PubMed ID: 8121119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathologic parameters and flow cytometric ploidy analysis in predicting recurrence in carcinoma of the prostate.
    Voges GE; Eigner EB; Ross W; Sussman H; Stöckle M; Freiha FS; Stamey TA
    Eur Urol; 1993; 24(1):132-9. PubMed ID: 8365433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Flow cytometry analysis of the DNA content of the prostate cancer--study on the tumor heterogeneity in prostate cancer].
    Michinaga S; Ariyoshi A; Kinjo M; Sagiyama K
    Nihon Hinyokika Gakkai Zasshi; 1996 Jun; 87(6):937-41. PubMed ID: 8753013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA ploidy patterns in androgen-deprived localized prostate cancer.
    Hellström M; Wester K; Häggman M; Brändstedt S; Busch C
    Eur Urol; 1996; 29(4):420-4. PubMed ID: 8791048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
    Currin SM; Lee SE; Walther PJ
    J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
    Lee SE; Currin SM; Paulson DF; Walther PJ
    J Urol; 1988 Oct; 140(4):769-74. PubMed ID: 3047437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometric DNA analysis of advanced prostatic adenocarcinoma.
    Wu WJ; Huang MS; Wang HJ; Chiang PH; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Mar; 9(3):122-30. PubMed ID: 8510195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA heterogeneity in prostatic adenocarcinoma. A DNA flow cytometric mapping study with whole organ sections of prostate.
    O'Malley FP; Grignon DJ; Keeney M; Kerkvliet N; McLean C
    Cancer; 1993 May; 71(9):2797-802. PubMed ID: 8467459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.